United Guardian (UG) EBITDA Margin Growth (3y) (2013 - 2026)
Powered by 
Analysis
United Guardian (UG) EBITDA Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 647.54 Bn | 626.78 Bn | 17.26 Bn | 120.00 |
| 2 | AbbVie | 441.45 Bn | 434.88 Bn | 12.70 Bn | 531.00 |
| 3 | Merck | 364.78 Bn | 357.64 Bn | 12.21 Bn | 3,082.00 |
| 4 | Novartis Ag | 267.01 Bn | 259.32 Bn | 11.24 Bn | 842.00 |
| 5 | Pfizer | 158.95 Bn | 147.25 Bn | 10.94 Bn | 214.00 |
| 6 | Sanofi | 52.54 Bn | 45.16 Bn | 10.79 Bn | -963.00 |
| 7 | Revolution Medicines | 44.23 Bn | 44.23 Bn | - | - |
| 8 | Incyte | 25.36 Bn | 20.82 Bn | 1.57 Bn | 2,139.00 |
| 9 | United Therapeutics | 21.31 Bn | 18.65 Bn | 683.80 Mn | -1,031.00 |
| 10 | United Guardian | 32.95 Mn | 23.36 Mn | 1.55 Mn | 471.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 471.00 |
| Mar 31, 2026 | -999.00 |
| Dec 31, 2025 | 100.00 |
| Sep 30, 2025 | -1,896.00 |
| Jun 30, 2025 | -859.00 |
| Mar 31, 2025 | -1,401.00 |
| Dec 31, 2024 | -1,461.00 |
| Sep 30, 2024 | -892.00 |
| Jun 30, 2024 | -855.00 |
| Mar 31, 2024 | -1,289.00 |
| Dec 31, 2023 | 894.00 |
| Sep 30, 2023 | -864.00 |
| Jun 30, 2023 | -1,646.00 |
| Mar 31, 2023 | -708.00 |
| Dec 31, 2022 | 4,029.00 |
| Sep 30, 2022 | -1,017.00 |
| Jun 30, 2022 | -399.00 |
| Mar 31, 2022 | -55.00 |
| Dec 31, 2021 | 525.00 |
| Sep 30, 2021 | -579.00 |